doi:10.48130/jsc-0025-0006

[1]

Australian Institute of Health and Welfare (AIHW). 2019. Australian Burden of Disease Study: impact and causes of illness and death in Australia 2015. Report, No. 19. AIHW, Australia. doi: 10.25816/5ebca2a4fa7dc

[2]

Clinical Oncology Society of Australia (COSA). 2020. Smoking cessation in cancer patients: embedding smoking cessation care in Australian Oncology Health Services. Report, No. 1, COSA, Australia https://www.cosa.org.au/media/332692/cosa-smoking-cessation-in-cancer-patients-140820-final.pdf

[3]

Baser S, Shannon VR, Eapen GA, Jimenez CA, Onn A, et al. 2006. Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status. Chest 130:1784−90

doi: 10.1016/S0012-3692(15)50902-1

[4]

Warren GW, Ward KD. 2015. Integration of tobacco cessation services into multidisciplinary lung cancer care: rationale, state of the art, and future directions. Translational Lung Cancer Research 4:339−52

doi: 10.3978/j.issn.2218-6751.2015.07.15

[5]

Gemine RE, Ghosal R, Collier G, Parry D, Campbell I, et al. 2019. Longitudinal study to assess impact of smoking at diagnosis and quitting on 1-year survival for people with non-small cell lung cancer. Lung Cancer 129:1−7

doi: 10.1016/j.lungcan.2018.12.028

[6]

Parsons A, Daley A, Begh R, Aveyard P. 2010. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 340:b5569

doi: 10.1136/bmj.b5569

[7]

Roach MC, Rehman S, DeWees TA, Abraham CD, Bradley JD, et al. 2016. It’s never too late: smoking cessation after stereotactic body radiation therapy for non-small cell lung carcinoma improves overall survival. Practical Radiation Oncology 6:12−18

doi: 10.1016/j.prro.2015.09.005

[8]

Daniel M, Keefe FJ, Lyna P, Peterson B, Garst J, et al. 2009. Persistent smoking after a diagnosis of lung cancer is associated with higher reported pain levels. The Journal of Pain 10:323−28

doi: 10.1016/j.jpain.2008.10.006

[9]

Garces YI, Yang P, Parkinson J, Zhao X, Wampfler JA, et al. 2004. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest 126:1733−41

doi: 10.1378/chest.126.6.1733

[10]

Caini S, Del Riccio M, Vettori V, Scotti V, Martinoli C, et al. 2022. Quitting smoking at or around diagnosis improves the overall survival of lung cancer patients: a systematic review and meta-analysis. Journal of Thoracic Oncology 17:623−36

doi: 10.1016/j.jtho.2021.12.005

[11]

Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, et al. 2020. The effect of advances in lung-cancer treatment on population mortality. New England Journal of Medicine 383:640−49

doi: 10.1056/NEJMoa1916623

[12]

Eberl M, Tanaka LF, Kraywinkel K, Klug SJ. 2022. Incidence of smoking-related second primary cancers after lung cancer in germany: an analysis of nationwide cancer registry data. Journal of Thoracic Oncology 17:388−98

doi: 10.1016/j.jtho.2021.11.016

[13]

Iragorri N, Essue B, Timmings C, Keen D, Bryant H, et al. 2020. The cost of failed first-line cancer treatment related to continued smoking in Canada. Current Oncology 27:307−12

doi: 10.3747/co.27.5951

[14]

Petrucci CM, Hyland A. 2019. Understanding the financial consequences of smoking during cancer treatment in the era of value-based medicine. JAMA Network Open 2:e191713

doi: 10.1001/jamanetworkopen.2019.1713

[15]

Warren GW, Cartmell KB, Garrett-Mayer E, Salloum RG, Cummings KM. 2019. Attributable failure of first-line cancer treatment and incremental costs associated with smoking by patients with cancer. JAMA Network Open 2:e191703

doi: 10.1001/jamanetworkopen.2019.1703

[16]

Shields PG, Herbst RS, Arenberg D, Benowitz NL, Bierut L, et al. 2016. Smoking cessation, version 1.2016, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network 14:1430−68

doi: 10.6004/jnccn.2016.0152

[17]

Kotz D, Brown J, West R. 2014. ‘Real-world’ effectiveness of smoking cessation treatments: a population study. Addiction 109:491−99

doi: 10.1111/add.12429

[18]

Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. 2016. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database of Systematic Reviews 3:CD008286

doi: 10.1002/14651858.CD008286.pub3

[19]

Day FL, Sherwood E, Chen TY, Barbouttis M, Varlow M, et al. 2018. Oncologist provision of smoking cessation support: a national survey of Australian medical and radiation oncologists. Asia-Pacific Journal of Clinical Oncology 14:431−38

doi: 10.1111/ajco.12876

[20]

Warren GW, Marshall JR, Cummings KM, Toll B, Gritz ER, et al. 2013. Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients. Journal of Thoracic Oncology 8:543−48

doi: 10.1097/JTO.0b013e318288dc96

[21]

Wells M, Aitchison P, Harris F, Ozakinci G, Radley A, et al. 2017. Barriers and facilitators to smoking cessation in a cancer context: a qualitative study of patient, family and professional views. BMC Cancer 17:348

doi: 10.1186/s12885-017-3344-z

[22]

Warren GW, Marshall JR, Cummings KM, Toll BA, Gritz ER, et al. 2013. Addressing tobacco use in patients with cancer: a survey of American Society of Clinical Oncology members. Journal of Oncology Practice 9:258−62

doi: 10.1200/JOP.2013.001025

[23]

Conlon K, Pattinson L, Hutton D. 2017. Attitudes of oncology healthcare practitioners towards smoking cessation: a systematic review of the facilitators, barriers and recommendations for delivery of advice and support to cancer patients. Radiography 23:256−63

doi: 10.1016/j.radi.2017.03.006

[24]

Australian Government Department of Health and Aged Care. 2023. National Tobacco Strategy 2023–2030. Canberra: Australian Government Department of Health and Aged Care https://www.health.gov.au/resources/publications/national-tobacco-strategy-2023-2030?language=en

[25]

Brierley J, Gospodarowicz MK, Wittekind C. 2017. TNM classification of malignant tumours. 8th Edition. Oxford, UK: Wiley-Blackwell https://www.wiley.com/en-us/TNM+Classification+of+Malignant+Tumours%2C+8th+Edition-p-9781119263562

[26]

Agustí A, Celli BR, Criner GJ, Halpin D, Anzueto A, et al. 2023. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Respirology 28:316−38

doi: 10.1111/resp.14486

[27]

R Core Team. 2021. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing https://www.R-project.org/

[28]

Walker MS, Vidrine DJ, Gritz ER, Larsen RJ, Yan Y, et al. 2006. Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Cancer Epidemiology, Biomarkers & Prevention 15:2370−77

doi: 10.1158/1055-9965.EPI-06-0509

[29]

Keeney E, Welton NJ, Stevenson M, Dalili MN, López-López JA, et al. 2021. Cost-effectiveness analysis of smoking cessation interventions in the United Kingdom accounting for major neuropsychiatric adverse events. Value in Health 24:780−88

doi: 10.1016/j.jval.2020.12.012

[30]

Fujisawa T, Iizasa T, Saitoh Y, Sekine Y, Motohashi S, et al. 1999. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. Journal of Clinical Oncology 17:2086−91

doi: 10.1200/JCO.1999.17.7.2086

[31]

Videtic GMM, Stitt LW, Dar AR, Kocha WI, Tomiak AT, et al. 2003. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. Journal of Clinical Oncology 21:1544−49

doi: 10.1200/JCO.2003.10.089

[32]

Sheikh M, Mukeriya A, Shangina O, Brennan P, Zaridze D. 2021. Postdiagnosis smoking cessation and reduced risk for lung cancer progression and mortality: a prospective cohort study. Annals of Internal Medicine 174:1232−39

doi: 10.7326/M21-0252

[33]

Tsao AS, Liu D, Lee JJ, Spitz M, Hong WK. 2006. Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer 106:2428−36

doi: 10.1002/cncr.21884

[34]

Ferketich AK, Niland JC, Mamet R, Zornosa C, D’Amico TA, et al. 2013. Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort. Cancer 119:847−53

doi: 10.1002/cncr.27824

[35]

Koshiaris C, Aveyard P, Oke J, Ryan R, Szatkowski L, et al. 2017. Smoking cessation and survival in lung, upper aero-digestive tract and bladder cancer: cohort study. British Journal of Cancer 117:1224−32

doi: 10.1038/bjc.2017.179

[36]

Dieleman LA, van Peet PG, Vos HMM. 2021. Gender differences within the barriers to smoking cessation and the preferences for interventions in primary care a qualitative study using focus groups in The Hague, The Netherlands. BMJ Open 11:e042623

doi: 10.1136/bmjopen-2020-042623

[37]

Ha SH, Lee GE, Hwang JS, Lee JH. 2024. Resistance to anti-smoking messages related to the higher smoking stigma of Korean female smokers. Frontiers in Psychology 15:1427201

doi: 10.3389/fpsyg.2024.1427201

[38]

Olson RE, Goldsmith L, Winter S, Spaulding E, Dunn N, et al. 2022. Emotions and lung cancer screening: prioritising a humanistic approach to care. Health & Social Care in the Community 30:e5259−e5269

doi: 10.1111/hsc.13945

[39]

Etter JF, Prokhorov AV, Perneger TV. 2002. Gender differences in the psychological determinants of cigarette smoking. Addiction 97:733−43

doi: 10.1046/j.1360-0443.2002.00135.x

[40]

Wetter DW, Kenford SL, Smith SS, Fiore MC, Jorenby DE, et al. 1999. Gender differences in smoking cessation. Journal of Consulting and Clinical Psychology 67:555−62

doi: 10.1037/0022-006X.67.4.555

[41]

Castaldelli-Maia JM, Nesoff ED, Lima DR, Sanchez ZM, Martins SS. 2022. The first day of smoking abstinence is more challenging for women than men: a meta-analysis and meta-regression across 12 low- and middle-income countries. Addictive Behaviors 128:107234

doi: 10.1016/j.addbeh.2021.107234

[42]

Bohadana A, Nilsson F, Rasmussen T, Martinet Y. 2003. Gender differences in quit rates following smoking cessation with combination nicotine therapy: influence of baseline smoking behavior. Nicotine & Tobacco Research 5:111−16

doi: 10.1080/1462220021000060482

[43]

Peltier MR, McKee SA. 2023. The role of sex hormones in targeting stress-induced tobacco craving, stress-reactivity, and smoking with guanfacine among women who smoke. Addiction Neuroscience 7:100084

doi: 10.1016/j.addicn.2023.100084

[44]

Ethier AR, McKinney TL, Tottenham LS, Gordon JL. 2021. The effect of reproductive hormones on women’s daily smoking across the menstrual cycle. Biology of Sex Differences 12:41

doi: 10.1186/s13293-021-00384-1

[45]

Ugalde A, White V, Rankin NM, Paul C, Segan C, et al. 2022. How can hospitals change practice to better implement smoking cessation interventions? A systematic review. CA: A Cancer Journal for Clinicians 72:266−86

doi: 10.3322/caac.21709

[46]

De Guzman KR, Snoswell CL, Puljevic C, Gupta D. 2020. Evaluating the utility of a Smoking Cessation Clinical Pathway tool to promote nicotine prescribing and use among inpatients of a tertiary hospital in Brisbane, Australia. Journal of Smoking Cessation 15:214−18

doi: 10.1017/jsc.2020.22

[47]

Young AL, Stefanovska E, Paul C, McCarter K, McEnallay M, et al. 2023. Implementing smoking cessation interventions for tobacco users within oncology settings: a systematic review. JAMA Oncology 9:981−1000

doi: 10.1001/jamaoncol.2023.0031

[48]

Nash J, Leong T, Dawkins P, Stone E, Marshall H, et al. 2024. The TSANZ and Lung Foundation Australia 2023 landscape survey of lung cancer care across Australia and Aotearoa New Zealand. Respirology 29:405−12

doi: 10.1111/resp.14693

[49]

Pistelli F, Aquilini F, Falaschi F, Puliti D, Ocello C, et al. 2020. Smoking cessation in the ITALUNG lung cancer screening: what does "teachable moment" mean? Nicotine & Tobacco Research 22:1484−91

doi: 10.1093/ntr/ntz148

[50]

Brain K, Carter B, Lifford KJ, Burke O, Devaraj A, et al. 2017. Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial. Thorax 72:912−18

doi: 10.1136/thoraxjnl-2016-209690

[51]

Taylor KL, Cox LS, Zincke N, Mehta L, McGuire C, et al. 2007. Lung cancer screening as a teachable moment for smoking cessation. Lung Cancer 56:125−34

doi: 10.1016/j.lungcan.2006.11.015

[52]

Tammemägi MC, Berg CD, Riley TL, Cunningham CR, Taylor KL. 2014. Impact of lung cancer screening results on smoking cessation. Journal of the National Cancer Institute 106:dju084

doi: 10.1093/jnci/dju084

[53]

Foley KL, Dressler EV, Weaver KE, Sutfin EL, Miller DP, Jr. , et al. 2023. The optimizing lung screening trial (WF-20817CD): multicenter randomized effectiveness implementation trial to increase tobacco use cessation for individuals undergoing lung screening. Chest 164:531−43

doi: 10.1016/j.chest.2023.03.013

[54]

Taylor KL, Williams RM, Li T, Luta G, Smith L, et al. 2022. A randomized trial of telephone-based smoking cessation treatment in the lung cancer screening setting. JNCI: Journal of the National Cancer Institute 114:1410−19

doi: 10.1093/jnci/djac127

[55]

Marshall HM, Courtney DA, Passmore LH, McCaul EM, Yang IA, et al. 2016. Brief tailored smoking cessation counseling in a lung cancer screening population is feasible: a pilot randomized controlled trial. Nicotine & Tobacco Research 18:1665−69

doi: 10.1093/ntr/ntw010

[56]

van der Aalst CM, de Koning HJ, van den Bergh KAM, Willemsen MC, van Klaveren RJ. 2012. The effectiveness of a computer-tailored smoking cessation intervention for participants in lung cancer screening: a randomised controlled trial. Lung Cancer 76:204−10

doi: 10.1016/j.lungcan.2011.10.006

[57]

Clark MM, Cox LS, Jett JR, Patten CA, Schroeder DR, et al. 2004. Effectiveness of smoking cessation self-help materials in a lung cancer screening population. Lung Cancer 44:13−21

doi: 10.1016/j.lungcan.2003.10.001